Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.39%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - P/B ratio
P/B ratio as of May 2024 : 1.02
According to Sage Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.02.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sage Therapeutics - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.63 | -10.18% |
| 2022-12-31 | 1.81 | 24.99% |
| 2021-12-31 | 1.45 | -40.43% |
| 2020-12-31 | 2.43 | -38.62% |
| 2019-12-31 | 3.96 | -23.83% |
| 2018-12-31 | 5.20 | -63.88% |
| 2017-12-31 | 14.4 | 179.81% |
| 2016-12-31 | 5.15 | -46.77% |
| 2015-12-31 | 9.67 | 25.74% |
| 2014-12-31 | 7.69 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | 6.97 | 583.81% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | 11.1 | 985.55% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 5.01 | 392.13% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | 0.2344 | -76.99% | 🇺🇸 USA |